Skip to content

The General Use of Robots in Stroke Recovery: the Anklebot

The General Use of Robots in Stroke Recovery: the Anklebot

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02249832
Enrollment
55
Registered
2014-09-26
Start date
2013-06-30
Completion date
2019-05-31
Last updated
2021-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Keywords

stroke, CVA, cerebrovascular accident, cerebral stroke, robotic therapy, anklebot, physical therapy

Brief summary

The purpose of this study is to determine if isolated robot-assisted training of the ankle joint improves chronic hemiparetic gait in patients after stroke.

Interventions

DEVICEseated robot-assisted ankle therapy

The MIT anklebot provides over one thousand total dorsi/plantar flexion and inversion/eversion robot-assisted movements of the ankle while in a seated position.

Sponsors

Northwell Health
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

All subjects received 18 sessions (3 times per week for 6 weeks) of seated robotic ankle training. Upon analysis, subjects were stratified by average admission gait speed on the 10 Meter Walk Test at comfortable pace, according to clinically established gait speed performance groups: low (\<0.4m/sec), moderate (0.4m/sec-0.8m/sec) and high (\>0.8m/sec) gait functioning.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 18 years of age or older * First single focal unilateral lesion with diagnosis verified by brain imaging, which occurred at least 6 months prior * Cognitive function sufficient enough to understand experiments and follow instructions * Some amount of independent ambulation (with orthoses or walker)

Exclusion criteria

* Botox treatment within 6-weeks of enrollment; * Fixed contraction deformity in the affected limb; * Complete and total flaccid paralysis of all lower extremity motor function; * Unable to ambulate except with the aid of another person

Design outcomes

Primary

MeasureTime frameDescription
Mean Change From Baseline in Gait Speed (m/Sec) on the 10 Meter Walk Test at Comfortable Pace.baseline, discharge (week 6), 3 month FU (overall week 18)Subjects were stratified based on average admission gait speed on the 10 Meter Walk Test at comfortable pace according to clinically established gait speed performance groups: low (\<0.4m/sec), moderate (0.4m/sec-0.8m/sec) and high (\>0.8m/sec) functioning. Mean gait speeds on the 10m Walk Test at comfortable pace (m/sec) were then compared across these three groups (low, moderate, and high function) at three timepoints (baseline, discharge (week 6), and 3 month FU (overall week 18)).

Secondary

MeasureTime frameDescription
Mean Change From Baseline in Gait Speed (m/Sec) on the 10 Meter Walk Test at Fast Pace.baseline, discharge (week 6), 3 month FU (overall week 18)Subjects were stratified based on average admission gait speed on the 10 Meter Walk Test at comfortable pace according to clinically established gait speed performance groups: low (\<0.4m/sec), moderate (0.4m/sec-0.8m/sec) and high (\>0.8m/sec) functioning. Mean gait speeds on the 10m Walk Test at fast pace (m/sec) were then compared across these three groups (low, moderate, and high function) at three timepoints (baseline, discharge (week 6), and 3 month FU (overall week 18)).
Mean Change From Baseline in Distance Walked (Meters) on the 6 Minute Walk Test at Comfortable Pace.baseline, discharge (week 6), 3 month FU (overall week 18)Subjects were stratified based on average admission gait speed on the 10 Meter Walk Test at comfortable pace according to clinically established gait speed performance groups: low (\<0.4m/sec), moderate (0.4m/sec-0.8m/sec) and high (\>0.8m/sec) functioning. Mean distance walked (m) on the 6 Minute Walk test at comfortable pace were then compared across these three groups (low, moderate, and high function) at three timepoints (baseline, discharge (week 6), and 3 month FU (overall week 18)).

Countries

United States

Participant flow

Pre-assignment details

All participants received eighteen sessions of seated anklebot training. Upon analysis, subjects were stratified based on average admission gait speed on the 10 Meter Walk Test at comfortable pace according to well standardized gait speed performance groups: low (\<0.4m/sec), moderate (0.4m/sec-0.8m/sec) and high (\>0.8m/sec) functioning.

Participants by arm

ArmCount
Seated Robotic Ankle Therapy
Participants received eighteen, 1 hour sessions (3 times/week for 6 weeks) of seated anklebot training with the MIT Anklebot.
55
Total55

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyLost to Follow-up10
Overall StudyWithdrawal by Subject3

Baseline characteristics

CharacteristicSeated Robotic Ankle Therapy
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
22 Participants
Age, Categorical
Between 18 and 65 years
33 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
8 Participants
Race (NIH/OMB)
Black or African American
6 Participants
Race (NIH/OMB)
More than one race
1 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
40 Participants
Region of Enrollment
United States
55 participants
Sex: Female, Male
Female
18 Participants
Sex: Female, Male
Male
37 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 55
other
Total, other adverse events
2 / 55
serious
Total, serious adverse events
1 / 55

Outcome results

Primary

Mean Change From Baseline in Gait Speed (m/Sec) on the 10 Meter Walk Test at Comfortable Pace.

Subjects were stratified based on average admission gait speed on the 10 Meter Walk Test at comfortable pace according to clinically established gait speed performance groups: low (\<0.4m/sec), moderate (0.4m/sec-0.8m/sec) and high (\>0.8m/sec) functioning. Mean gait speeds on the 10m Walk Test at comfortable pace (m/sec) were then compared across these three groups (low, moderate, and high function) at three timepoints (baseline, discharge (week 6), and 3 month FU (overall week 18)).

Time frame: baseline, discharge (week 6), 3 month FU (overall week 18)

Population: Subjects were stratified according to clinically established gait speed impairment levels based on average admission gait speed on the 10 Meter Walk Test at comfortable pace.

ArmMeasureGroupValue (MEAN)Dispersion
Low Gait Speed GroupMean Change From Baseline in Gait Speed (m/Sec) on the 10 Meter Walk Test at Comfortable Pace.Mean gait speed at discharge (week 6)0.26 m/secStandard Error 0.02
Low Gait Speed GroupMean Change From Baseline in Gait Speed (m/Sec) on the 10 Meter Walk Test at Comfortable Pace.Mean gait speed at baseline0.22 m/secStandard Error 0.02
Low Gait Speed GroupMean Change From Baseline in Gait Speed (m/Sec) on the 10 Meter Walk Test at Comfortable Pace.Mean gait speed at 3month FU (overall week 18)0.24 m/secStandard Error 0.02
Moderate Gait Speed GroupMean Change From Baseline in Gait Speed (m/Sec) on the 10 Meter Walk Test at Comfortable Pace.Mean gait speed at discharge (week 6)0.62 m/secStandard Error 0.04
Moderate Gait Speed GroupMean Change From Baseline in Gait Speed (m/Sec) on the 10 Meter Walk Test at Comfortable Pace.Mean gait speed at baseline0.53 m/secStandard Error 0.03
Moderate Gait Speed GroupMean Change From Baseline in Gait Speed (m/Sec) on the 10 Meter Walk Test at Comfortable Pace.Mean gait speed at 3month FU (overall week 18)0.66 m/secStandard Error 0.04
High Gait Speed GroupMean Change From Baseline in Gait Speed (m/Sec) on the 10 Meter Walk Test at Comfortable Pace.Mean gait speed at baseline1.02 m/secStandard Error 0.07
High Gait Speed GroupMean Change From Baseline in Gait Speed (m/Sec) on the 10 Meter Walk Test at Comfortable Pace.Mean gait speed at 3month FU (overall week 18)1.29 m/secStandard Error 0.1
High Gait Speed GroupMean Change From Baseline in Gait Speed (m/Sec) on the 10 Meter Walk Test at Comfortable Pace.Mean gait speed at discharge (week 6)1.18 m/secStandard Error 0.12
p-value: <0.001ANOVA
Secondary

Mean Change From Baseline in Distance Walked (Meters) on the 6 Minute Walk Test at Comfortable Pace.

Subjects were stratified based on average admission gait speed on the 10 Meter Walk Test at comfortable pace according to clinically established gait speed performance groups: low (\<0.4m/sec), moderate (0.4m/sec-0.8m/sec) and high (\>0.8m/sec) functioning. Mean distance walked (m) on the 6 Minute Walk test at comfortable pace were then compared across these three groups (low, moderate, and high function) at three timepoints (baseline, discharge (week 6), and 3 month FU (overall week 18)).

Time frame: baseline, discharge (week 6), 3 month FU (overall week 18)

Population: Subjects were stratified based on average admission gait speed on the 10 Meter Walk Test at comfortable pace according to clinically established gait speed performance levels.

ArmMeasureGroupValue (MEAN)Dispersion
Low Gait Speed GroupMean Change From Baseline in Distance Walked (Meters) on the 6 Minute Walk Test at Comfortable Pace.mean distance at 3 month FU (overall week18)75.07 metersStandard Error 5.62
Low Gait Speed GroupMean Change From Baseline in Distance Walked (Meters) on the 6 Minute Walk Test at Comfortable Pace.mean distance at baseline68.46 metersStandard Error 5.76
Low Gait Speed GroupMean Change From Baseline in Distance Walked (Meters) on the 6 Minute Walk Test at Comfortable Pace.mean distance at discharge (week 6)79.33 metersStandard Error 5.38
Moderate Gait Speed GroupMean Change From Baseline in Distance Walked (Meters) on the 6 Minute Walk Test at Comfortable Pace.mean distance at 3 month FU (overall week18)183.34 metersStandard Error 14.33
Moderate Gait Speed GroupMean Change From Baseline in Distance Walked (Meters) on the 6 Minute Walk Test at Comfortable Pace.mean distance at baseline152.92 metersStandard Error 9.53
Moderate Gait Speed GroupMean Change From Baseline in Distance Walked (Meters) on the 6 Minute Walk Test at Comfortable Pace.mean distance at discharge (week 6)180.11 metersStandard Error 11.64
High Gait Speed GroupMean Change From Baseline in Distance Walked (Meters) on the 6 Minute Walk Test at Comfortable Pace.mean distance at 3 month FU (overall week18)314.43 metersStandard Error 21.46
High Gait Speed GroupMean Change From Baseline in Distance Walked (Meters) on the 6 Minute Walk Test at Comfortable Pace.mean distance at baseline280.43 metersStandard Error 19.19
High Gait Speed GroupMean Change From Baseline in Distance Walked (Meters) on the 6 Minute Walk Test at Comfortable Pace.mean distance at discharge (week 6)319.79 metersStandard Error 22.91
p-value: 0.001ANOVA
Secondary

Mean Change From Baseline in Gait Speed (m/Sec) on the 10 Meter Walk Test at Fast Pace.

Subjects were stratified based on average admission gait speed on the 10 Meter Walk Test at comfortable pace according to clinically established gait speed performance groups: low (\<0.4m/sec), moderate (0.4m/sec-0.8m/sec) and high (\>0.8m/sec) functioning. Mean gait speeds on the 10m Walk Test at fast pace (m/sec) were then compared across these three groups (low, moderate, and high function) at three timepoints (baseline, discharge (week 6), and 3 month FU (overall week 18)).

Time frame: baseline, discharge (week 6), 3 month FU (overall week 18)

Population: Subjects were stratified according to clinically established gait speed impairment levels based on average admission gait speed on the 10 Meter Walk Test at comfortable pace.

ArmMeasureGroupValue (MEAN)Dispersion
Low Gait Speed GroupMean Change From Baseline in Gait Speed (m/Sec) on the 10 Meter Walk Test at Fast Pace.mean gait speed at 3 month FU (overall week 18)0.27 m/secStandard Error 0.03
Low Gait Speed GroupMean Change From Baseline in Gait Speed (m/Sec) on the 10 Meter Walk Test at Fast Pace.mean gait speed at discharge (week 6)0.29 m/secStandard Error 0.03
Low Gait Speed GroupMean Change From Baseline in Gait Speed (m/Sec) on the 10 Meter Walk Test at Fast Pace.mean gait speed at baseline0.25 m/secStandard Error 0.02
Moderate Gait Speed GroupMean Change From Baseline in Gait Speed (m/Sec) on the 10 Meter Walk Test at Fast Pace.mean gait speed at discharge (week 6)0.79 m/secStandard Error 0.06
Moderate Gait Speed GroupMean Change From Baseline in Gait Speed (m/Sec) on the 10 Meter Walk Test at Fast Pace.mean gait speed at baseline0.67 m/secStandard Error 0.06
Moderate Gait Speed GroupMean Change From Baseline in Gait Speed (m/Sec) on the 10 Meter Walk Test at Fast Pace.mean gait speed at 3 month FU (overall week 18)0.84 m/secStandard Error 0.1
High Gait Speed GroupMean Change From Baseline in Gait Speed (m/Sec) on the 10 Meter Walk Test at Fast Pace.mean gait speed at baseline1.30 m/secStandard Error 0.13
High Gait Speed GroupMean Change From Baseline in Gait Speed (m/Sec) on the 10 Meter Walk Test at Fast Pace.mean gait speed at 3 month FU (overall week 18)1.79 m/secStandard Error 0.26
High Gait Speed GroupMean Change From Baseline in Gait Speed (m/Sec) on the 10 Meter Walk Test at Fast Pace.mean gait speed at discharge (week 6)1.41 m/secStandard Error 0.18
Comparison: A 3x3 repeated measures ANOVA was performed with group (mean gait speed in the low, moderate, and high groups) and time (admission, discharge (week 6), and follow-up (overall week 18) in each condition) as factors. Null hypothesis was that there was no difference in mean gait speed over time across the three groups. A significance level of 0.05 was used (two-sided).p-value: <0.001ANOVA

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026